» Articles » PMID: 11750898

Soluble Oligomers of Beta Amyloid (1-42) Inhibit Long-term Potentiation but Not Long-term Depression in Rat Dentate Gyrus

Overview
Journal Brain Res
Specialty Neurology
Date 2001 Dec 26
PMID 11750898
Citations 233
Authors
Affiliations
Soon will be listed here.
Abstract

The dementia in Alzheimer disease (AD) is usually attributed to widespread neuronal loss in conjunction with the pathologic hallmarks of intracellular neurofibrillary tangles and extracellular plaques containing amyloid (A beta) in fibrillar form. Recently it has been demonstrated that non-fibrillar assemblies of A beta possess electrophysiologic activity, with the corollary that they may produce dementia by disrupting neuronal signaling prior to cell death. We therefore examined the effects of soluble oligomers of A beta(1-42) on long-term potentiation (LTP) and long-term depression (LTD), two cellular models of memory, in the dentate gyrus of rat hippocampal slices. Compared with vehicle controls, slices pre-incubated 60 min in the presence of A beta-derived diffusible ligands (ADDLs) showed no differences in threshold intensity to evoke a synaptic response, slope of field excitatory post-synaptic potentials (EPSPs), or the input/output function. Tetanus-induced LTP and reversal of LTD were strongly inhibited in ADDLs-treated slices whereas LTD was unaffected. These data suggest that soluble non-fibrillar amyloid may contribute to the pathogenesis of AD both by impairing LTP/memory formation at the cellular level and by creating 'neuroplasticity imbalance' manifested by unopposed LTD in the setting of impaired capacity for neural repair via reversal of LTD or LTP.

Citing Articles

Cellular Prion Protein and Amyloid-β Oligomers in Alzheimer's Disease-Are There Connections?.

Fulek M, Hachiya N, Gachowska M, Beszlej J, Bartoszewska E, Kurpas D Int J Mol Sci. 2025; 26(5).

PMID: 40076721 PMC: 11900156. DOI: 10.3390/ijms26052097.


Patient-derived tau and amyloid-β facilitate long-term depression : role of tumour necrosis factor-α and the integrated stress response.

Hu N, Ondrejcak T, Klyubin I, Yang Y, Walsh D, Livesey F Brain Commun. 2024; 6(5):fcae333.

PMID: 39391333 PMC: 11465085. DOI: 10.1093/braincomms/fcae333.


Neuroprotective Effects of Ferrostatin and Necrostatin Against Entorhinal Amyloidopathy-Induced Electrophysiological Alterations Mediated by voltage-gated Ca Channels in the Dentate Gyrus Granular Cells.

Naderi S, Motamedi F, Pourbadie H, Rafiei S, Khodagholi F, Naderi N Neurochem Res. 2023; 49(1):99-116.

PMID: 37615884 DOI: 10.1007/s11064-023-04006-7.


Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.

Ali T, Klein A, Vu A, Arifin M, Hannaoui S, Gilch S Cell Mol Life Sci. 2023; 80(6):139.

PMID: 37149826 PMC: 10164677. DOI: 10.1007/s00018-023-04785-w.


Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases.

Kulenkampff K, Wolf Perez A, Sormanni P, Habchi J, Vendruscolo M Nat Rev Chem. 2023; 5(4):277-294.

PMID: 37117282 DOI: 10.1038/s41570-021-00254-9.